OrganiGram Authorized by Health Canada to Sell Cannabis Oils

Visit the OrganiGram Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

Organigram large logo

OrganiGram Holdings Inc. Receives License to Sell Oil Extracts

MONCTON, NEW BRUNSWICK, Jun 22, 2016 (Marketwired via COMTEX) — MONCTON, NEW BRUNSWICK–(Marketwired – Jun 22, 2016) – OrganiGram Holdings Inc. (OGI)(otcqb:OGRMF) (the “Company”) a provider of cannabis products, is pleased to announce that the company has received an amendment to its license to include both the production and sale of cannabis oil extracts from Health Canada under the Marihuana for Medical Purposes Regulations (Canada) (“MMPR”) at its facility in Moncton, New Brunswick. The license was upgraded from production only and provides OrganiGram with the ability to produce and sell cannabis oil extracts along with our current dried medical cannabis products.

This addition to our suite of products falls in line with our ongoing strategy of improved product diversity, customer satisfaction and production expansion as our industry continues to move forward towards a recreational marketplace.

denis arsenaultDenis Arsenault, CEO of OrganiGram

OrganiGram also announces the issuance of 54,674 shares to XIB Consulting Inc. for services performed pursuant to the arrangement previously announced.

We would also like to take this opportunity to announce that Roger Rogers will be stepping down from his position on the Board of Directors of OrganiGram Holdings Inc. effective immediately. We would like to thank Roger for his contribution to the Board and wish him the best of success in his future endeavours.

About OrganiGram Holdings Inc.

OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. OrganiGram’s facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.


OrganiGram Holdings Inc.
Giselle Doiron
Director of Investor and Media Relations
(506) 801-8986

Original press release:

For fact-based information on Organigram, view the company’s sponsored Investor Dashboard.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter